228 related articles for article (PubMed ID: 9366420)
1. Autoantigen recognition by human CD8 T cell clones: enhanced agonist response induced by altered peptide ligands.
Dressel A; Chin JL; Sette A; Gausling R; Höllsberg P; Hafler DA
J Immunol; 1997 Nov; 159(10):4943-51. PubMed ID: 9366420
[TBL] [Abstract][Full Text] [Related]
2. Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen.
Zaremba S; Barzaga E; Zhu M; Soares N; Tsang KY; Schlom J
Cancer Res; 1997 Oct; 57(20):4570-7. PubMed ID: 9377571
[TBL] [Abstract][Full Text] [Related]
3. Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals.
Berthelot L; Laplaud DA; Pettré S; Ballet C; Michel L; Hillion S; Braudeau C; Connan F; Lefrère F; Wiertlewski S; Guillet JG; Brouard S; Choppin J; Soulillou JP
Eur J Immunol; 2008 Jul; 38(7):1889-99. PubMed ID: 18506883
[TBL] [Abstract][Full Text] [Related]
4. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic activity and lymphokine production of T cell receptor (TCR)-alpha beta+ and TCR-gamma delta+ cytotoxic T lymphocyte (CTL) clones recognizing HLA-A2 and HLA-A2 mutants. Recognition of TCR-gamma delta+ CTL clones is affected by mutations at positions 152 and 156.
Spits H; Paliard X; Engelhard VH; de Vries JE
J Immunol; 1990 Jun; 144(11):4156-62. PubMed ID: 2111341
[TBL] [Abstract][Full Text] [Related]
6. MHC class I-restricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes.
Jurewicz A; Biddison WE; Antel JP
J Immunol; 1998 Mar; 160(6):3056-9. PubMed ID: 9510211
[TBL] [Abstract][Full Text] [Related]
7. Rational optimization of tumor epitopes using in silico analysis-assisted substitution of TCR contact residues.
Shang X; Wang L; Niu W; Meng G; Fu X; Ni B; Lin Z; Yang Z; Chen X; Wu Y
Eur J Immunol; 2009 Aug; 39(8):2248-58. PubMed ID: 19593772
[TBL] [Abstract][Full Text] [Related]
8. Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology.
Hemmer B; Vergelli M; Gran B; Ling N; Conlon P; Pinilla C; Houghten R; McFarland HF; Martin R
J Immunol; 1998 Apr; 160(8):3631-6. PubMed ID: 9558061
[TBL] [Abstract][Full Text] [Related]
9. Peptide recognition by two HLA-A2/Tax11-19-specific T cell clones in relationship to their MHC/peptide/TCR crystal structures.
Hausmann S; Biddison WE; Smith KJ; Ding YH; Garboczi DN; Utz U; Wiley DC; Wucherpfennig KW
J Immunol; 1999 May; 162(9):5389-97. PubMed ID: 10228016
[TBL] [Abstract][Full Text] [Related]
10. Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme.
Bondurant KL; Crew MD; Santin AD; O'Brien TJ; Cannon MJ
Clin Cancer Res; 2005 May; 11(9):3446-54. PubMed ID: 15867247
[TBL] [Abstract][Full Text] [Related]
11. Identification of CD19 and CD20 peptides for induction of antigen-specific CTLs against B-cell malignancies.
Bae J; Martinson JA; Klingemann HG
Clin Cancer Res; 2005 Feb; 11(4):1629-38. PubMed ID: 15746068
[TBL] [Abstract][Full Text] [Related]
12. Specificity of human T cell clones reactive to immunodominant epitopes of myelin basic protein.
Chou YK; Henderikx P; Vainiene M; Whitham R; Bourdette D; Chou CH; Hashim G; Offner H; Vandenbark AA
J Neurosci Res; 1991 Feb; 28(2):280-90. PubMed ID: 1709690
[TBL] [Abstract][Full Text] [Related]
13. Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87-99).
Vergelli M; Hemmer B; Utz U; Vogt A; Kalbus M; Tranquill L; Conlon P; Ling N; Steinman L; McFarland HF; Martin R
Eur J Immunol; 1996 Nov; 26(11):2624-34. PubMed ID: 8921948
[TBL] [Abstract][Full Text] [Related]
14. Altered peptide ligands of islet autoantigen Imogen 38 inhibit antigen specific T cell reactivity in human type-1 diabetes.
Geluk A; van Meijgaarden KE; Roep BO; Ottenhoff TH
J Autoimmun; 1998 Aug; 11(4):353-61. PubMed ID: 9776713
[TBL] [Abstract][Full Text] [Related]
15. Suboptimal activation of CD8(+) T cells by melanoma-derived altered peptide ligands: role of Melan-A/MART-1 optimized analogues.
Carrabba MG; Castelli C; Maeurer MJ; Squarcina P; Cova A; Pilla L; Renkvist N; Parmiani G; Rivoltini L
Cancer Res; 2003 Apr; 63(7):1560-7. PubMed ID: 12670905
[TBL] [Abstract][Full Text] [Related]
16. Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein.
Butterfield LH; Koh A; Meng W; Vollmer CM; Ribas A; Dissette V; Lee E; Glaspy JA; McBride WH; Economou JS
Cancer Res; 1999 Jul; 59(13):3134-42. PubMed ID: 10397256
[TBL] [Abstract][Full Text] [Related]
17. Highly conserved pattern of recognition of influenza A wild-type and variant CD8+ CTL epitopes in HLA-A2+ humans and transgenic HLA-A2+/H2 class I-deficient mice.
Hu N; D'Souza C; Cheung H; Lang H; Cheuk E; Chamberlain JW
Vaccine; 2005 Nov; 23(45):5231-44. PubMed ID: 16099553
[TBL] [Abstract][Full Text] [Related]
18. Synthetic anticancer vaccine candidates: rational design of antigenic peptide mimetics that activate tumor-specific T-cells.
Douat-Casassus C; Marchand-Geneste N; Diez E; Gervois N; Jotereau F; Quideau S
J Med Chem; 2007 Apr; 50(7):1598-609. PubMed ID: 17328535
[TBL] [Abstract][Full Text] [Related]
19. Activation and control of pathogenic T cells in OSP/claudin-11-induced EAE in SJL/J mice are dominated by their focused recognition of a single epitopic residue (OSP58M).
Kaushansky N; Eisenstein M; Oved JH; Ben-Nun A
Int Immunol; 2008 Nov; 20(11):1439-49. PubMed ID: 18801757
[TBL] [Abstract][Full Text] [Related]
20. Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of Southern China and Taiwan.
Lin HJ; Cherng JM; Hung MS; Sayion Y; Lin JC
J Biomed Sci; 2005 Dec; 12(6):925-36. PubMed ID: 16307312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
